Investor FAQs

Show All
Where is Evelo headquartered?
The Company’s headquarters are located at 620 Memorial Drive, Suite 200 West, Cambridge, MA 02139. The main office number is 617-577-0300.
On what stock exchange are Evelo’s shares traded and what is the ticker symbol?
Evelo stock is traded on the NASDAQ Global Market under the ticker EVLO.
When did the Company go public?
Evelo completed its IPO in May 2018.
What is Evelo’s CUSIP number?
The CUSIP number for the Company’s common stock is 299734 103.
Does Evelo have a direct purchase stock plan?
Evelo does not currently have a direct stock purchase plan. The Company’s common stock can be purchased by contacting a securities broker of your choice.
Does Evelo have a dividend reinvestment program?
Evelo does not currently offer a dividend reinvestment program and does not expect to declare or pay cash or other dividends in our common stock in the foreseeable future.
Who is Evelo’s transfer agent?

The transfer agent for the common stock of Evelo is:

American Stock Transfer and Trust Company, LLC
6201 15th Avenue | Brooklyn, NY 11219

When does Evelo’s fiscal year end?
The Company’s fiscal year ends on December 31st.
When is the annual meeting of shareholders?
The date of our next annual meeting has not yet been set.
Who are Evelo’s legal counsel and independent auditors?
Our legal counsel is:
Latham & Watkins LLP
200 Clarendon Street
Boston, MA 02116
617-880-4500

Our independent auditor is:

Ernst & Young, LLP
200 Clarendon Street
Boston, MA 02116
Where can I get the latest corporate news releases and financial reports?
Corporate news releases can be found under News Releases on our Investors webpage. Quarterly and annual reports, as well as other SEC filings, can be found in the SEC Filings section of our Investors webpage or directly from the SEC at www.sec.gov.
Whom should I contact if I have further questions?
You can reach our Investor Relations team by contacting ir@evelobio.com.